SharpLink Gaming Announces Third Quarter 2023 Financial Results
November 14, 2023 08:30 ET
|
SharpLink Gaming Ltd.
Revenues Increase to $3.3 Million and $9.9 Million from $1.3 Million and $4.9 Million for the Comparable Three- and Nine-Month Reporting Periods, Respectively MINNEAPOLIS, Nov. 14, 2023 (GLOBE...
SRM Entertainment Reports Third Quarter 2023 Financial Results
November 14, 2023 08:30 ET
|
SRM Entertainment, Inc.
Completed NASDAQ listing Launched Smurfs & Zoonicorn Sip with Me® cups Multi-year license agreements JUPITER, FL, Nov. 14, 2023 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (Nasdaq:...
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 14, 2023 08:00 ET
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 14, 2023 07:30 ET
|
DMK Pharmaceuticals Corporation
Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid related deaths through enhanced sales of ZIMHI®...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
November 13, 2023 16:10 ET
|
Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022 HOUSTON, TEXAS, Nov. ...
Calian to Hold Conference Call Following Announcement of Fourth Quarter FY 2023 Results
November 13, 2023 12:34 ET
|
Calian Group Ltd.
Calian® Group Ltd. (TSX:CGY) will hold a conference call at 8:30 a.m. Eastern Time on Tuesday, November 28, 2023, to discuss Fourth Quarter FY 2023 Results
Calian tiendra une conférence téléphonique après l’annonce des résultats du quatrième trimestre de l’exercice 2023
November 13, 2023 12:34 ET
|
Calian Group Ltd.
OTTAWA, 13 nov. 2023 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), société de produits et services divers qui fournit des solutions novatrices dans les domaines des soins de santé, des...
Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023 08:00 ET
|
Sagimet Biosciences Inc.
On track to report topline week 52 liver biopsy results from Phase 2b FASCINATE-2 trial with denifanstat in the first quarter of 2024 Two abstracts, including late-breaker, accepted at the American...
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
November 13, 2023 08:00 ET
|
Cocrystal Pharma, Inc.
Enrollment underway in Phase 1 trial with novel protease inhibitor CDI-988, the first potential dual coronavirus-norovirus oral antiviralDosing expected to begin later this year in Phase 2a human...
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2023
November 13, 2023 07:28 ET
|
Investview, Inc.
Haverford, PA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU), a diversified financial technology company that through its subsidiaries and global distribution network provides...